Related references
Note: Only part of the references are listed.CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma
Xiao-Lu Ma et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update
Joseph A. Clara et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
AP-1 and TGFß cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma
Catherine D. Yao et al.
NATURE COMMUNICATIONS (2020)
Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis
Atsushi Hiraoka et al.
HEPATOLOGY RESEARCH (2019)
Lenvatinib: A Review in Hepatocellular Carcinoma
Zaina T. Al-Salama et al.
DRUGS (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Long-term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion
Haruhiko Takeda et al.
HEPATOLOGY RESEARCH (2019)
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis
Atsushi Hiraoka et al.
CANCER MEDICINE (2019)
Noncoding RNAs in liver cancer stem cells: The big impact of little things
Hongwei Lv et al.
CANCER LETTERS (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models
Masahiro Matsuki et al.
CANCER MEDICINE (2018)
Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy
Olga Gordeeva
SEMINARS IN CANCER BIOLOGY (2018)
The molecular connection of histopathological heterogeneity in hepatocellular carcinoma: A role of Wnt and Hedgehog signaling pathways
Anindita Tripathy et al.
PLOS ONE (2018)
Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
Victoria Tovar et al.
GUT (2017)
Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors
Miroslava Didiasova et al.
FASEB JOURNAL (2017)
Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets
Marcel Klingenberg et al.
JOURNAL OF HEPATOLOGY (2017)
Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells
Xiaoqi Huo et al.
MOLECULAR CANCER (2017)
Antagonism of EGFR and Notch limits resistance to EGFR inhibitors and radiation by decreasing tumor-initiating cell frequency
Shi Hu et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Implication of the Hedgehog pathway in hepatocellular carcinoma
Carminia Maria Della Corte et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1
Li Liu et al.
CELL DEATH & DISEASE (2017)
Pirfenidone normalizes the tumor microenvironment to improve chemotherapy
Christiana Polydorou et al.
ONCOTARGET (2017)
Pirfenidone Inhibits Proliferation and Promotes Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway
Wei-Jie Zou et al.
MEDICAL SCIENCE MONITOR (2017)
Aberrant hedgehog signaling is responsible for the highly invasive behavior of a subpopulation of hepatoma cells
Y-H Fan et al.
ONCOGENE (2016)
Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement
Rashmi Bharti et al.
CANCER LETTERS (2016)
Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: From patients to patient-derived tumor xenograft models
Qihong Zhao et al.
ONCOTARGET (2016)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
Hedgehog-GLI Signaling Inhibition Suppresses Tumor Growth in Squamous Lung Cancer
Lingling Huang et al.
CLINICAL CANCER RESEARCH (2014)
Targeting cancer stem cells to suppress acquired chemotherapy resistance
S. J. Vidal et al.
ONCOGENE (2014)
Down-Regulation of Gli Transcription Factor Leads to the Inhibition of Migration and Invasion of Ovarian Cancer Cells via Integrin β4-Mediated FAK Signaling
Qi Chen et al.
PLOS ONE (2014)
GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis
Ritesh K. Srivastava et al.
ONCOTARGET (2014)
The critical role of CD133+CD44+/high tumor cells in hematogenous metastasis of liver cancers
Ying Hou et al.
CELL RESEARCH (2012)
CD133+liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling
Kwan Ho Tang et al.
HEPATOLOGY (2012)
Gefitinib resistance in HCC mahlavu cells: Upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation
Adam S. Bodzin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Smoothened Antagonists Reverse Taxane Resistance in Ovarian Cancer
Adam D. Steg et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Clinical Implications of Cancer Stem Cell Biology in Hepatocellular Carcinoma
Junfang Ji et al.
SEMINARS IN ONCOLOGY (2012)
Targeting cancer stem cells by inhibiting Wnt, notch, and Hedgehog pathways
Naoko Takebe et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
The Hedgehog's tale: developing strategies for targeting cancer
Jessica M. Y. Ng et al.
NATURE REVIEWS CANCER (2011)
Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma
Zheng Zhu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
CD133+ Liver Cancer Stem Cells from Methionine Adenosyl Transferase 1A-Deficient Mice Demonstrate Resistance to Transforming Growth Factor (TGF)-β-Induced Apoptosis
Wei Ding et al.
HEPATOLOGY (2009)
Identification and characterization of tumorigenic liver cancer stem/progenitor cells
Stephanie Ma et al.
GASTROENTEROLOGY (2007)
Share Paper
